Sonal Gidwani

Title: Sonal Gidwani: Innovator in RSV Research

Introduction

Sonal Gidwani is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of respiratory syncytial virus (RSV) research. With a total of 2 patents, her work focuses on developing innovative solutions for vaccination and therapeutic methods.

Latest Patents

Sonal Gidwani's latest patents include the development of conformationally stabilized RSV pre-fusion F proteins. The present invention provides mutant RSV F molecules that can be stabilized in a pre-fusion conformation through the introduction of one or more DT cross-links. This invention also outlines methods for creating such mutant RSV F molecules, compositions that include these molecules, and various applications, such as vaccination methods, therapeutic methods, and antibody production methods.

Career Highlights

Throughout her career, Sonal has demonstrated a commitment to advancing medical research and innovation. Her work has the potential to significantly impact the treatment and prevention of RSV, a virus that poses serious health risks, particularly to infants and the elderly.

Collaborations

Sonal collaborates with talented individuals in her field, including Mark Yondola and Aaron Zomback. These partnerships enhance her research efforts and contribute to the development of groundbreaking solutions in RSV treatment.

Conclusion

Sonal Gidwani is a dedicated inventor whose work in RSV research is paving the way for new therapeutic and vaccination methods. Her innovative patents and collaborations highlight her commitment to improving public health through scientific advancements.